Anúncio
Anúncio
BEAM
Beam Therapeutics Inc. Common Stock
27.11
USDPatrocinado
-0.61
-2.19%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
27.20
+0.09
+0.34%
Relatórios de Lucros BEAM
Rácio de surpresa positiva
BEAM separação 14 de 24 últimas estimativas.
58%
Próximo Relatório
Data do Próximo Relatório
23 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$13.29M
/-$1.16
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+37.08%
/+5.45%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-55.79%
/+6.42%
Beam Therapeutics Inc. Common Stock earnings per share and revenue
On 04 de nov. de 2025, BEAM reported earnings of -1.10 USD per share (EPS) for Q3 25, missing the estimate of -1.06 USD, resulting in a -3.72% surprise. Revenue reached 9.70 milhão, compared to an expected 12.66 milhão, with a -23.41% difference. The market reacted with a -6.23% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analistas forecast an EPS of -1.16 USD, with revenue projected to reach 13.29 milhão USD, implying an aumentar of 5.45% EPS, and aumentar of 37.08% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Beam Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Beam Therapeutics Inc. Common Stock reported EPS of -$1.10, missing estimates by -3.72%, and revenue of $9.70M, -23.41% below expectations.
How did the market react to Beam Therapeutics Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -6.23%, changed from $24.25 before the earnings release to $22.74 the day after.
When is Beam Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for 23 de fev. de 2026.
What are the forecasts for Beam Therapeutics Inc. Common Stock's next earnings report?
Based on 16
analistas, Beam Therapeutics Inc. Common Stock is expected to report EPS of -$1.16 and revenue of $13.29M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio